Functional and Value-Added Dairy Products and Blood Glucose Control

Sponsor
Mount Saint Vincent University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05400694
Collaborator
University of Toronto (Other)
20
1
5
17.9
1.1

Study Details

Study Description

Brief Summary

Milk proteins possess multiple biological activities including their effect on blood glucose control, satiety and energy intake. The design of functional food products with added milk protein fractions has many challenges related to their inferior sensory properties. Chocolate milk presents the universal vehicle for added milk protein fractions that might partially mask their sensory characteristics. However, commercially produced chocolate milk has a significant amount of added sugar. This project will investigate the properties of a value-added dairy product (chocolate milk with reduced sugar content) enriched with individual milk protein fractions on characteristics of blood glucose control, satiety and energy intake in young healthy adults.

Condition or Disease Intervention/Treatment Phase
  • Other: Food
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Masking Description:
Treatments are blinded.
Primary Purpose:
Prevention
Official Title:
The Sensory and Metabolic Effects of Functional and Value-Added Dairy Products
Actual Study Start Date :
Oct 1, 2021
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Mar 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Chocolate milk

Chocolate milk with reduced added sugar

Other: Food
Dairy products with reduced sugar content

Experimental: Chocolate milk with whey protein

Chocolate milk with reduced added sugar and added whey protein

Other: Food
Dairy products with reduced sugar content

Experimental: Chocolate milk with casein

Chocolate milk with reduced added sugar and added casein

Other: Food
Dairy products with reduced sugar content

Experimental: Chocolate milk with alpha-lactalbumin

Chocolate milk with reduced added sugar and added alpha-lactalbumin

Other: Food
Dairy products with reduced sugar content

Experimental: Chocolate milk with glycomacropeptide

Chocolate milk with reduced added sugar and added glycomacropeptide

Other: Food
Dairy products with reduced sugar content

Outcome Measures

Primary Outcome Measures

  1. Blood glucose [0-120 minutes]

    The concentration of blood glucose

  2. Insulin [0-120 minutes]

    The concentration of insulin

Secondary Outcome Measures

  1. C-peptide [0-120 minutes]

    The concentration of C-peptide

  2. Incretins, glucagon and amino acids [0-120 minutes]

    The concentration of incretins and glucagon

  3. Satiety [0-120 minutes]

    The components of average subjective appetite including desire to eat, hunger, fullness, and a prospective food consumption measured with 100mm visual analogue scales.

  4. Food Intake [0 min, 120 minutes]

    Energy intake with an ad libitum meat at 120 minutes

  5. Thirst [0-120 minutes]

    The subjective perception of thirst measured with 100mm visual analogue scales containing the question "How thirsty do you feel?" and two statements on each pole of 100mm line: "Not thirsty at all" (0mm) and "As thirsty as I have ever felt" (100mm).

  6. Physical comfort [0-120 minutes]

    The subjective feeling of wellness and gastrointestinal discomfort parameters including the feeling of nausea, stomach cramps, flatulency, diarrhea and a subjective feeling of wellness, each measured with 100mm visual analogue scales.

  7. Food pleasantness [at 0 and 120 minutes]

    The perception of pleasantness of the treatments (0 min) and a test meal (at 120 min) will be measured with 100mm visual analogue scale.

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 19-35 y males and females, non-smokers
Exclusion Criteria:
  • having any diseases, irregular menses in females, smoking (all types), taking medications known to influence blood glucose control, skipping breakfast, and having emotional, or learning problems that would affect their ability to participate in the study as required. Individuals with known food allergies and lactose intolerance will be also excluded.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mount Saint Vincent University Halifax Nova Scotia Canada B3M 2J6

Sponsors and Collaborators

  • Mount Saint Vincent University
  • University of Toronto

Investigators

  • Principal Investigator: Bohdan Luhovyy, PhD, Mount Saint Vincent University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bohdan Luhovyy, Associate Professor, Mount Saint Vincent University
ClinicalTrials.gov Identifier:
NCT05400694
Other Study ID Numbers:
  • 2019-202-02
First Posted:
Jun 1, 2022
Last Update Posted:
Jun 1, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bohdan Luhovyy, Associate Professor, Mount Saint Vincent University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 1, 2022